《大行報告》匯豐研究下調嘉里(00683.HK)目標價至23.5元 評級「買入」
匯豐環球研究發表報告指,嘉里建設(00683.HK)今年上半年基礎盈利按年增長18%至28億元,若撇除出售兩個倉庫的收益,基礎盈利為按年倒退27%。集團上半年表現是大致符合該行預期,即物業銷售因本港第五波疫情而受壓。
匯豐表示,長期的疫情限制對集團的租賃業務表現帶來負面影響,並較該行預期為差,但預期業務於今年下半年會有溫和復甦。
匯豐研究下調嘉里股份目標價,由25.2元降至23.5元,評級維持「買入」,並調整集團今年至2024年盈利預測,由下調5.8%至上調2.1%不等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.